Phreesia Inc
$ 11.66
-0.34%
24 Feb - close price
- Market Cap 705,358,000 USD
- Current Price $ 11.66
- High / Low $ 11.90 / 11.43
- Stock P/E N/A
- Book Value 5.32
- EPS -0.09
- Next Earning Report 2026-03-30
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE -0.02 %
- 52 Week High 32.76
- 52 Week Low 11.43
About
Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.
Analyst Target Price
$28.05
Quarterly Earnings
| Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-12-08 | 2025-09-05 | 2025-05-28 | 2025-03-12 | 2024-12-09 | 2024-09-04 | 2024-05-30 | 2024-03-14 | 2023-12-05 | 2023-09-06 | 2023-05-31 | 2023-03-22 |
| Reported EPS | 0.07 | 0.01 | 0.2259 | 0.1848 | 0.0367 | -0.31 | -0.35 | -0.21 | -0.25 | -0.34 | -0.38 | -0.43 |
| Estimated EPS | -0.0014 | -0.06 | -0.42 | 0.1106 | -0.27 | -0.36 | -0.48 | -0.26 | -0.36 | -0.42 | -0.46 | -0.51 |
| Surprise | 0.0714 | 0.07 | 0.6459 | 0.0742 | 0.3067 | 0.05 | 0.13 | 0.05 | 0.11 | 0.08 | 0.08 | 0.08 |
| Surprise Percentage | 5100% | 116.6667% | 153.7857% | 67.0886% | 113.5926% | 13.8889% | 27.0833% | 19.2308% | 30.5556% | 19.0476% | 17.3913% | 15.6863% |
Next Quarterly Earnings
| Jan 2026 | |
|---|---|
| Reported Date | 2026-03-30 |
| Fiscal Date Ending | 2026-01-31 |
| Estimated EPS | 0.1 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PHR
2026-02-23 21:50:10
Phreesia has appointed Jon Kessler to its Board of Directors, effective April 6, 2026, to enhance its technology-driven growth and governance expertise. This appointment coincides with the retirement of longtime directors Edward Cahill and Board Chair Michael Weintraub at the 2026 Annual Meeting, leading to a streamlined seven-member board. The company aims to strengthen its platform, launch new offerings, and boost shareholder value with Kessler's extensive experience in healthcare financial services.
2026-02-23 21:03:28
Phreesia (NYSE: PHR) has appointed Jon Kessler, former CEO of HealthEquity, to its Board of Directors, effective April 6, 2026. This appointment aims to leverage Kessler's expertise in healthcare financial services and technological innovation, aligning with Phreesia's mission to enhance patient care through technology. Additionally, long-serving directors Edward L. Cahill and Michael Weintraub will retire from the board at the 2026 Annual Meeting.
2026-02-20 20:55:10
JP Morgan has lowered its price target for Phreesia (PHR) from $29.00 to $24.00, while maintaining an "Overweight" rating. This adjustment follows several other analysts who have also reduced their price targets for PHR recently, though generally maintaining positive ratings. Despite these adjustments, the average target price from Wall Street analysts suggests a significant upside of 125.42% from its current price, and GuruFocus estimates an even higher fair value for the stock.
2026-02-18 19:57:36
Johnson Fistel, PLLP is investigating potential claims on behalf of investors in Phreesia, Inc. (NYSE: PHR) following a significant 25% drop in stock price on December 9, 2025. The investigation focuses on whether Phreesia's executive officers complied with federal securities laws, stemming from updated fiscal 2026 revenue guidance during an earnings call. Shareholders who suffered losses are encouraged to contact Johnson Fistel for more information about potentially recovering their investments.
2026-02-17 20:57:55
Phreesia, Inc. announced that it will release its fiscal fourth quarter and fiscal year 2026 financial results after market close on Monday, March 30, 2026. The company will also hold a conference call and webcast on the same day at 5 PM Eastern Time to discuss these results. Details for accessing the press release, stakeholder letter, and the call are available on Phreesia's investor website.
2026-02-13 06:27:43
Phreesia, Inc. (NYSE:PHR) shares have dropped 27% in the last month, contributing to a 56% loss over the past year. Despite a low price-to-sales (P/S) ratio of 1.6x compared to the industry average, and revenue growth that aligns with or exceeds industry forecasts, shareholders remain cautious. This suggests investors are doubtful about future revenue stability, possibly due to perceived risks.
